The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma

Published:2018-02-07 Issue:2 Volume:15 Page:103-108
ISSN:1612-9059
Container-title:Esophagus
language:en
Short-container-title:Esophagus

Author:

Akutsu Yasunori,Murakami Kentaro,Kano Masayuki,Toyozumi Takeshi,Matsumoto Yasunori,Takahashi Masahiko,Otsuka Ryota,Sekino Nobufumi,Yokoyama Masaya,Shiraishi Tadashi,Matsubara Hisahiro

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s10388-018-0604-1/fulltext.html

Reference25 articles.

1. Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2008. Esophagus. 2015;12(2):130–57.

2. Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2007. Esophagus. 2015;12(2):101–29.

3. Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257(6):1032–8.

4. Holscher AH, Bollschweiler E, Schroder W, Metzger R, Gutschow C, Drebber U. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg. 2011;254(5):802–7 (discussion 7–8).

5. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11(11):3887–95.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contrast‐enhanced CT‐based radiomic analysis for determining the response to anti‐programmed death‐1 therapy in esophageal squamous cell carcinoma patients: A pilot study;Thoracic Cancer;2023-09-24

2. Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers;Biomarkers;2023-07-02

3. Soluble PD‑L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse‑free survival after radical surgery;Molecular and Clinical Oncology;2023-03-20

4. Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis;Frontiers in Oncology;2022-11-17

5. Soluble PD-L1 Concentration Is Proportional to the Expression of PD-L1 in Tissue and Is Associated with a Poor Prognosis in Esophageal Squamous Cell Carcinoma;Oncology;2021-12-06